A substitution for a highly conserved non-glycine residue in the triple-helical domain of the proa2(I) collagen molecule was found in an individual with a variant of the Marfan syndrome.
Introduction
Type I collagen is the most abundant collagen and the major protein in many tissues including skin, bone, ligament, tendon, sclera, cornea, and blood vessels (reviewed in references 1 and 2). The presence of type I collagen in many different tissues implies that it has diverse functional roles. For example, type I collagen provides tensile strength in bone, skin, and tendon, but normally supports mineralization only in bones and teeth. Certain functions of type I collagen must be related primarily to its structural features, but others, such as support for mineral deposition may depend on its interactions with other matrix macromolecules.
The ubiquity of type I collagen and its functional diversity are reflected in different clinical disorders which are associated with genetic abnormalities that affect type I collagen structure or biosynthesis. The principal manifestation of mutations in type I collagen that alter the sites for extracellular processing of the amino propeptide is severe joint laxity (Ehlers-Danlos; type VII) (3) (4) (5) (6) . Genetic defects resulting in deficient posttranslational lysyl hydroxylation offibrillar collagen molecules in some tissues produces joint laxity, muscle hypotonia, scoliosis, and may predispose the individual to vascular rupture (7, 8) . Osteogenesis imperfecta, a disorder in which the primary clinical effect is osteopenia, is due to mutations that decrease the rate of type I collagen biosynthesis or result in disruption of the triple helix (reviewed in reference 1). Thus analyses of genetic abnormalities of type I collagen or its processing have contributed to defining some of its functional roles.
Although the stringent requirement for glycine at every third position in the triple-helical domain has been made clear by the finding of many glycyl substitutions associated with osteogenesis imperfecta, there is little direct information regarding the function of most non-glycine residues in the triple helical domain. For a few residues, there is evidence of involvement in collagen crosslinking (9) or in degradation (10) . But at present, the requirement for most non-glycine residues of the triple-helical domain has only been inferred by relative rates of conservation between species. In this study we report an amino acid substitution at a non-glycyl residue in the triple-helical domain of the proa2(I) collagen molecule. This single base mutation converts the highly conserved arginine618 at the Y position of a Gly-X-Y repeat to glutamine, and is responsible for the abnormal migration in SDS-polyacrylamide gels of proa2(I) chains of type I collagen synthesized by cells from a proband with cardiovascular and skeletal features of the Marfan syndrome (1 1). Family studies show that this substitution was inherited from the proband's father, who shares the same type I collagen phenotype biochemically as well as some of the proband's abnormal skeletal features.
Methods
Clinical summary. Detailed clinical information on the proband has been previously reported (I 1). In brief, she had progressive lumbar scoliosis noted before age 10. At age 30, aortic dilation and aortic regurgitation was noted. By age 37, aortic dilation resulted in congestive heart failure, and the aortic valve and a portion of the ascending aorta were replaced with a porcine heterograft. Examination at age 39 revealed arachnodactyly and a decreased upper to lower segment ratio. Eye exam showed mild myopia but no lens dislocation.
The patient's father suffered from chronic lung disease and chronic renal failure. He had a history of mild myopia, but no history ofjoint hyperextensibility or dislocation. Physical exam at age 78 revealed absence ofjoint hyperextensibility, limb disproportion, and arachno-dactyly. He died at age 78 from heart failure thought to be secondary to chronic lung disease. Autopsy revealed an enlarged heart with biventricular hypertrophy; heart valves were thickened, but otherwise normal. The ascending aorta was normal in diameter; there was a moderate amount ofatherosclerosis, and aortic atheromas were thought to be calcified to an excessive degree. Postmortem examination ofthe vertebral column showed there was significant upper thoracic kyphosis with marked irregularities in the vertebral body size and outline.
The proband's mother and sibling are both alive and in relatively good health without evidence of a connective tissue disorder.
Cell strains. Human skin fibroblasts from the proband and family members ofthe proband were provided by Dr. Peter Byers (University of Washington, Seattle). The cells were grown to confluence in Dulbecco's modified Eagle's medium buffered to pH 7.4, with 24 mM sodium bicarbonate and 25 mM Hepes, and supplemented with 20% calf serum (Gibco Laboratories, Grand Island, NY) that had been heat inactivated for 30 min at 560C. The atmosphere was maintained at 5% carbon dioxide per 95% air at 370C.
Preparation and separation of collagens synthesized by cultured cells. The cultured dermal fibroblasts were seeded at a density of 250,000 per 35 mm tissue culture dish 24 h before labeling. Cultures were then washed twice with PBS and preincubated in serum-free medium containing 100 M/ml penicillin G sodium, 100 ,g/ml streptomycin sulfate, 50 MAM ascorbic acid. After 3-4 h of preincubation, the medium was replaced with 700 Ml of serum-free medium with ascorbate, containing 100 MCi 2,3,4,5-[3H]proline, and incubated for an additional 16 h. Then [3H]proline-labeled procollagens were harvested and a chain-sized molecules were prepared by partial digestion with pepsin. The a chains were separated by SDS-PAGE in a 2 M urea, 5.0% polyacrylamide gel as previously described (12) .
Synthesis and cloning of double-stranded cDNA. Total RNA was isolated from skin fibroblasts which had been seeded at a density of 400,000 per 100 mm diam tissue culture dish and grown to confluence. Before isolation, cultures were washed twice with PBS and incubated for 72 h in medium containing 100 MM L-ascorbic acid. Total RNA was isolated using the procedure described by Chomczynski and Sacchi (13). Poly A RNA was prepared from total RNA by oligo-dT chromatography (14) and used to synthesize double-stranded cDNA (15) with the following modification. For first-strand synthesis, the poly A RNA (9.0 ,ug) was primed using a specific proa2(I) collagen oligonucleotide (20mer: 5'GACTCCAGGACTACCCACAG'3), 1.05 ,ug, complimentary to nucleotide positions 2867-2886 of the proa2(I) collagen mRNA (16). Second-strand cDNA synthesis proceeded as described (15) .
The region ofthe cDNA which codes for the a2(I)CB3 peptide and the a2(I)CB5 peptide amino-terminal to the fibroblast collagenase cleavage site was amplified by the polymerase chain reaction (PCR)' (17) using 20-base oligonucleotide primers. The 3'oligonucleotide primer (5'GCACCAGCAACACCAGGTAG'3) was complimentary to nucleotides 2785-2804 of the proa2(I) cDNA and the 5'oligonucleotide primer (5'CGAGGACCTAATGGAGATGC'3) corresponded to nucleotides 1429-1448. The denaturating, annealing, and extending conditions for PCR were 1.5 min at 94°C, 2 min at 55°C, and 3 min at 72°C, respectively. The PCR products were examined for different size species by agarose gel electrophoresis, using a 1.5% agarose gel 25 cm in length, which was run at 35 V for 48 h. PCR products were then either digested with the Bsu36 I (New England Biolabs, Beverly, MA), which restricts at the same site as Sau I and Mst II, and the products separated by electrophoresis, or they were ligated into Sma I-digested pUC 18 or pUC 19 vectors (Bethesda Research Laboratories, Bethesda, MD). The ligation mix was then transformed into the Escherichia coli strain, DH5a (Bethesda Research Laboratories).
Five positive clones were isolated, their plasmids purified (18) , and the double-stranded cDNAs were sequenced by the dideoxy method 1. Abbreviations used in this paper: PCR, polymerase chain reaction. using T7 DNA polymerase (Sequenase; United States Biochemical Corp., Gaithersburg, MD).
Southern blot analysis. The 3.0-kb Eco RI genomic fragment, containing exons 32-37 ofCOLIA2 (16, 19) (Fig. 4 B) Since there was no evidence for an insertion of coding sequences, the PCR-amplified cDNA which codes for residues 357-775 was cloned into pUC18 or pUC19 and sequenced. We isolated and sequenced five clones that had the correct size insert (1,375 bp) and the predicted 5' and 3' ends.
The proband was found to be heterozygous for a single nucleotide change that results in an amino acid substitution of glutamine for the arginine at position 618 in the triple-helical domain of the a2(I) collagen chain (Fig. 1) . This single nucleotide change, G to A, was predicted to create a new Bsu36 I (Sau I, Mst II) restriction site (recognition sequence CC/ TNAGG) in both the cDNA and genomic DNA from this individual. The amplified PCR product and the cDNA clones from the normal and abnormal alleles were digested with the restriction enzyme Bsu36 I and the DNA fragments size fractionated by agarose gel electrophoresis. The cDNA fragments from the normal allele ( Fig. 2; lane 6) show a 557-bp fragment that is digested into 440-and 11 7-bp fragments in the abnormal allele ( Fig. 2; fragments were present in the Bsu36 I-digested PCR fraction from this proband (Fig. 2) . To determine whether this substitution was an inherited or a de novo mutation, proa2(I) collagen cDNAs were synthe- sized and amplified from poly A RNA from fibroblast cells of the proband's family. The PCR products were examined for this Bsu36 I site (Fig. 2) . The mother and sister ofthe proband are homozygous for the normal allele, and the father is heterozygous for the normal and abnormal alleles, suggesting that the substitution of a glutamine for an arginine was inherited from the proband's father. In order to determine if the father also produces an abnormal a2(I) chain, the procollagens synthesized by the proband and the proband's family were examined.
[H3]Proline-labeled collagenous proteins harvested from fibroblasts were treated with pepsin to remove the nontriple-helical domains of the procollagen and then separated by SDS-PAGE (Fig. 3) . The proband and the father synthesized a population of a2(I) chains that migrated more slowly than normal, resulting in a broad a2(I) band. This suggests that the arginine to glutamine substitution may account for this abnormal migrating a2(I) chain found in both the father and the proband.
To investigate whether this amino acid substitution was a common polymorphism we examined the proband's family, 52 control caucasian individuals (103 chromosomes), and four individuals (7 chromosomes) with osteogenesis imperfecta who had defined mutations by Southern blot analysis for the novel Bsu36 I restriction site. Only genomic DNA from the proband and the proband's father were positive for the new Bsu36 I site (Fig. 4) , which suggests that this mutation is not a common polymorphism. These results also confirmed that both the proband and the proband's father were heterozygous for this amino acid substitution and it was not the result of an artifact in amplification or cloning. In addition, we also examined 17 probands who fulfilled all clinical criteria for the Marfan syndrome (Bsu36 I blots were generously provided by Dr. Clair Francomano, John Hopkins University, Baltimore, MD) for the new Bsu36 I site; it was absent in all of them.
Discussion
In this report we demonstrate that the presence ofan abnormal proa2(I) chain of type I collagen previously reported in an individual with several features ofthe Marfan syndrome is due to a substitution at a non-glycine position in the triple-helical domain. Sequence analysis of cDNA's amplified by the polymerase chain reaction and of genomic DNA indicate that a Y-positioned arginine at triple-helical residue 618 is replaced There is little doubt that the glutamine for arginine618 substitution results in the change in electrophoretic mobility in SDS-polyacrylamide gels that was reported in earlier studies by Byers et al. (1 1) . We isolated cDNAs that contained continuous coding sequences for the entire region of the proa2(I) chain responsible for the altered migration. Two populations of cDNA clones were sequenced in their entirety. They differed only at nucleotide position 2258, which is within the codon for position 618 of the triple helix. Evidence that these two cDNA populations reflected both alleles was confirmed both by sequence analysis ofthe PCR products of the patient's COL I A2 genomic DNA and by Southern blot analysis of Bsu36 I-digested genomic DNA. The substitution of a neutral glutamine for a basic arginine is consistent with the finding of an acidic charge shift in the abnormal peptide reported by Byers et al. (1 1) . Delayed migration of peptides in SDS-polyacrylamide gels resulting from single amino acid substitutions have been previously reported (21, 22) . Most relevant is the report by Noel et al. that a cysteine for arginine substitution in the histidine binding protein, hisJ5625 of Salmonella typhimurium, retarded migration in SDS-PAGE (22) .
The functional role of arginine618 of proa2(I) chain in type I collagen and the possible mechanism by which a nonconservative substitution at that position might produce a Marfanlike phenotype is more difficult to determine. There is genetic evidence that arginine618 may have an important functional or structural role. Arginine618 is conserved not only across species, in chick, and bovine COL1A2 (23) , but also in all the known human fibrillar collagen genes for which sequences are available: COLlAl (24), COL2A1 (25) , COL3A1 (26), and COL5A2 (27) , all of which diverged from COL1A2 before diversion of human and chick ancestors. Arginine618 also appears to be part of one of many charged domains in the type I collagen molecule that are highly conserved (28). Segment long spacing crystallite studies (2) and later sequence analyses confirm the highly conserved nature of the charged residues in the fibrillar collagens. The substitution of glutamine for arginine618 may affect intermolecular alignment during fibril formation, which may explain the finding of increased extractability ofthe collagen from this individual's skin (1 1). The finding that arginine618 is highly conserved is consistent with data suggesting that this substitution is not a common polymorphism.
Abnormalities in type I collagen have been previously implicated in the Marfan syndrome by reports of accelerated collagen synthesis and turnover (29) , abnormal crosslinking (30) , and increased solubility of both skin collagen and newly synthesized collagen of patients with Marfan syndrome (31 (37) . Although the skeletal and cardiovascular abnormalities present in the proband in this report are important characteristics of the Marfan syndrome, they are not restricted to it.
Normal development and function of these tissues are under the control of many genes, and it is possible that subtle alterations in type I collagen structure may play a role in connective tissue disorders that are characterized by familial clustering of cardiovascular and/or musculoskeletal abnormalities (38) . Significant intrafamilial differences in clinical severity such as that seen between the proband in this report and her father are seen in many inherited connective tissue disorders, reflecting the complex polygenic nature of extracellular matrix biosynthesis. In addition, the greatly increased incidence in females over males in such connective tissue disorders as mitral valve prolapse and scoliosis is consistent with both the complexity of extracellular matrix biosynthesis and with the finding of limited clinical abnormalities in the father of the female proband in this report. Finally, these data also suggest that heterozygous substitutions at non-glycine residues in the triple helical domain of type I collagen chains are insufficiently disruptive to bone matrix biosynthesis to produce the osteogenesis imperfecta clinical phenotype (reviewed in reference 1).
